" class="no-js "lang="en-US"> Uncategorized Archives - Medtech Alert
Friday, March 29, 2024

Sort by:

Date

Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]

Remington Announces Launch of VascuChek®, A Wireless, Vascular Doppler Device

Remington Medical, a medical device manufacturing company based in the U.S., announced the launch of […]

Telix and RefleXion Expand Partnership for Prostate Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) […]

Fluent Biosciences Launches Industry's First Single Tube 100,000 Cell Product to Enable Unprecedented Scale, Cost-efficiency and Access for Single-cell RNA Sequencing

Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to […]

Flagship Biosciences Hires Tom Turi, Ph.D., as New Chief Scientific Officer

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring […]

Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah

Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more